AfricaBP aims to foster grassroots knowledge exchange in biodiversity genomics and bioinformatics

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros. – Biotech Investments

EQS-News: MPH Health Care AG / Key word(s): Preliminary Results/Annual Results MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million

April 26, 2024

Vorasidenib for Low-Grade Glioma Doubles Progression-Free Survival

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a global phase III trial showing that the targeted therapy vorasidenib more

July 1, 2023

Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant | Psychedelic Invest

NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that the Company has entered

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.